/PRNewswire/ Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company) a leader in the development of targeted radiotherapies, today.
Actinium Pharma (ATNM) Reports Positive 1-Year and 2-Year Overall Survival Data for Patients with Relapsed or Refractory AML streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
One thing that John Imig, Ph.D., really values is connections. His varied research interests help him find links between disease states. He enjoys passing knowledge on to the next generation. He’s also passionate about bridging the gap between basic science and human health. Imig arrived at UAMS on Sept. 29…